Compare BBSI & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBSI | BVS |
|---|---|---|
| Founded | 1965 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 799.2M | 716.8M |
| IPO Year | 1994 | 2016 |
| Metric | BBSI | BVS |
|---|---|---|
| Price | $33.13 | $8.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $42.67 | $14.00 |
| AVG Volume (30 Days) | 211.5K | ★ 667.8K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | 5.05 | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | ★ $920,432,000.00 | $568,087,000.00 |
| Revenue This Year | $6.59 | $7.52 |
| Revenue Next Year | $6.05 | $7.06 |
| P/E Ratio | ★ N/A | $212.00 |
| Revenue Growth | ★ 9.50 | N/A |
| 52 Week Low | $25.33 | $5.81 |
| 52 Week High | $49.65 | $11.25 |
| Indicator | BBSI | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 57.76 | 43.50 |
| Support Level | $26.54 | $8.43 |
| Resistance Level | $37.80 | $9.27 |
| Average True Range (ATR) | 1.31 | 0.38 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 42.45 | 55.87 |
Barrett Business Services Inc is a provider of business management solutions for small and mid-sized companies through a platform that combines management consulting expertise with human resource tools to help business owners manage and operate their businesses more effectively. The company has two categories of services: Professional Employer Services (PEO) and Staffing. The majority of revenue is derived from the Professional Employer Services segment, which provides clients with human resource advisory services, HRIS access, retirement plans, a learning management system, and a web-based technology platform, myBBSI.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.